Document:

[LOGO]

                  CORPORATE FINANCE ADVISORY SERVICES AGREEMENT

FRIEDLAND CORPORATE INVESTOR SERVICES LLC ("FRIEDLAND") hereby agrees to provide
to China Agri-Business, Inc. (the "Company") corporate finance advisory services
specifically and primarily designed to assist the Company in forming a Chinese
owned Wholly-Owned Foreign Enterprise ("WOFE"), and the Company becoming
publicly-traded in the United States.

1.    COSTS FOR ADVISORY SERVICES

1.1   Payment in Shares. The advisory services to be provided by FRIEDLAND shall
      commence upon the receipt by FRIEDLAND of an executed copy of this
      Advisory Services Agreement and the issuance by the Company to FRIEDLAND
      (or designees of FRIEDLAND) of shares of the common stock of the Company
      (the "Stock"), with the understanding that the Stock shall represent no
      less than 10% of the Company's shares outstanding, on a fully diluted
      basis, at the time of commencement of trading of the Company's shares. .

1.2   Payment in Cash. Upon the establishment of a trading market for the
      Company's shares in the United States, the Company shall pay to FRIEDLAND,
      the US dollar equivalent of RMB 750,000 by wire transfer to FRIEDLAND's
      account in the United States.

1.3   Stock Certificates. Certificates representing the Stock shall be
      registered in FRIEDLAND's name (or designees of FRIEDLAND) (or an
      appropriate book entry shall be made). Certificates shall be issued to
      FRIEDLAND and registered in the name of FRIEDLAND (or designees of
      FRIEDLAND).

1.4   Adjustments to Stock. If there is any change, increase or decrease, in the
      outstanding shares of the Company's common stock which is effected without
      receipt of additional consideration by the Company, by reason of a stock
      dividend, stock split, recapitalization, merger, consolidation,
      combination or exchange of stock, or other similar circumstances, or if
      there is a spin-off or other distribution of assets to the Company's
      stockholders, other than the acquisition of the Target, the Company shall
      make an appropriate adjustment in the aggregate number of shares of Stock.
      Such adjustment shall be identical to the adjustment made generally with
      respect to outstanding shares of the Company's common stock. Any
      additional securities or other property issued to FRIEDLAND as a result of
      any of the foregoing events shall continue to be subject to the terms of
      this Agreement to the same extent as the Stock giving rise to the right to
      receive such additional securities or other property.

3.    DISCLOSURE

      Additionally, it is acknowledged that FRIEDLAND, or an affiliate of
      FRIEDLAND may enter, or has entered into a services agreement with a
      privately-held Chinese company that may enter into a business relationship
      with the WOFE, and FRIEDLAND may be receiving cash fees from the
      privately-held Chinese company.

4.    REPRESENTATION AND WARRANTIES

4.1   Company. The Company represents and warrants to FRIEDLAND as follows: (i)
      The Company has been duly formed; (ii) the execution of this Agreement has
      been duly authorized by the Company and does not require the consent of or
      notice to any party not previously obtained or given, and (iii)The Company
      shall indemnify and save FRIEDLAND harmless against any claims, damages,
      liabilities and causes of action, including but not limited to reasonable
      attorney fees, which arise by reason of the consulting services provided
      by FRIEDLAND hereunder, or by reason of an act FRIEDLAND may do on behalf
      of, or at the request of the Company, providing that FRIEDLAND's actions
      and activities in providing consulting services hereunder, and any such
      act undertaken by FRIEDLAND on behalf of, or at the request of the
      Company, actions or activities are consistent with the provisions of this
      Agreement, are undertaken in good faith, and do not involve gross
      negligence or wanton or willful misconduct by FRIEDLAND.

                                       1
<PAGE>

4.2   FRIEDLAND. FRIEDLAND represents and warrants to the Company as follows:
      (i) FRIEDLAND has been duly formed under the laws of the State of
      Colorado; (ii) the execution of this Agreement and the performance of
      FRIEDLAND'S obligations hereunder does not require the consent of or
      notice to any party not previously obtained or given, and, there is
      nothing that prohibits or restricts the execution by FRIEDLAND of this
      Agreement or its performance of its obligations hereunder.

4.3   FRIEDLAND's Investment Representations. FRIEDLAND acknowledges that the
      Stock to be issued by the Company pursuant to this Agreement has not been
      registered under the Securities Act, or any applicable state securities
      laws, and is being offered and sold pursuant to exemptions from such
      registration requirements based in part upon FRIEDLAND's representations
      and acknowledgments contained in this Agreement, including the following:

      (a)   FRIEDLAND warrants and represents to the Company that FRIEDLAND is
            acquiring the Stock on FRIEDLAND's own account for investment and
            not with a view to or for sale in connection with any distribution
            of the Stock or with any present intention of distributing or
            selling the Stock and Participant does not presently have reason to
            anticipate any change in circumstances or any particular occasion or
            event which would cause FRIEDLAND to sell the Stock;

      (b)   FRIEDLAND acknowledges that FRIEDLAND must bear the economic risk of
            this investment indefinitely unless the Stock is registered pursuant
            to the Securities Act and applicable state securities laws or an
            exemption from such registration is available;

      (c)   FRIEDLAND understands there is no assurance that any exemption from
            registration under the Securities Act and applicable state
            securities laws will be available in the future; and

      (d)   FRIEDLAND represents that, by reason of FRIEDLAND's relationship
            with the Company and FRIEDLAND's business and financial expertise,
            FRIEDLAND has the capacity to protect FRIEDLAND's own interests in
            connection with the transactions contemplated by this Agreement.

5.    COVENANTS

      Each of FRIEDLAND and the Company covenant that it will diligently,
      skillfully and in good faith do and perform the acts and duties required
      herein.

6.    MISCELLANEOUS

6.1   Rights as a Stockholder. FRIEDLAND shall have, with respect to the Stock,
      all of the rights of a stockholder of the Company, including the right to
      vote the Stock and the right to receive any dividends or other
      distributions with respect thereto.

6.2   Validity of Share Issuance. The shares of Stock have been duly authorized
      by all necessary corporate action of the Company and are validly issued,
      fully paid and non-assessable.

6.3   Further Action. The parties agree to execute such further instruments and
      to take such further action as reasonably may be necessary to carry out
      the intent of this Agreement.

6.4   Notice. All notices, requests, demands, directions and other
      communications ("Notices") provided for in this Agreement shall be in
      writing and shall be mailed or delivered personally or sent by facsimile
      to the applicable Party at the address of such Party set forth below in
      this Section 6.4. When mailed, each such Notice shall be sent by first
      class, certified mail, return receipt requested, enclosed in a postage
      prepaid wrapper, and shall be effective on the third business day after it
      has been deposited in the mail. When delivered personally, each such
      Notice shall be effective on the first business day on which or after
      which it is delivered to the address for the respective Party set forth in
      this Section 6.4. When sent by facsimile, each such Notice shall be
      effective on the first business day on which or after which it is sent.
      Each such Notice shall be addressed to the Party to be notified as shown
      below:

                                       2
<PAGE>

      THE COMPANY:   China Agri-Business, Inc.
                     Attention: Mark Shaner, President
                     70 South Potomac
                     Aurora, CO 80012
                     Fax: (303) 865-1056

      FRIEDLAND:     FRIEDLAND CORPORATE INVESTOR SERVICES LLC
                     Attention: Jeffrey O. Friedland, Managing Member
                     36 Steele Street, Suite 10
                     Denver, CO 80206
                     Fax: 1-212-202-4436

      Either Party may change its respective address for purposes of this
      Section 6.4 by giving the other Party Notice of the new address in the
      manner set forth above.

6.5   Severability. Whenever possible, each provision of this Agreement shall be
      interpreted in such a manner as to be effective and valid under applicable
      law. If any provision of this Agreement shall be or become prohibited or
      invalid in whole or in part for any reason whatsoever, that provision
      shall be ineffective only to the extent of such prohibition or invalidity
      without invalidating the remaining portion of that provision or the
      remaining provisions of this Agreement.

6.6   Non-Waiver. The waiver of any Party of a breach or a violation of any
      provision of this Agreement shall not operate or be construed as a waiver
      of any subsequent breach or violation of any provision of this Agreement.

6.7   Amendment. No amendment or modification of this Agreement shall be deemed
      effective unless and until it has been executed in writing by the Parties
      to this Agreement. No term or condition of this Agreement shall be deemed
      to have been waived, nor shall there be any estoppel to enforce any
      provision of this Agreement, except by a written instrument that has been
      executed by the Party charged with such waiver or estoppel.

6.8   Inurement. This Agreement shall be binding upon all of the Parties, and it
      shall benefit, respectively, each of the Parties, and their respective
      employees, agents and successors. Except as expressly provided herein,
      there are no third party beneficiaries to this Agreement, and this
      Agreement shall not be assignable by any party.

6.9   Headings. The headings to this Agreement are for convenience only; they
      form no part of this Agreement and shall not affect its interpretation.

6.10  Counterparts. This Agreement may be executed in one or more counterparts,
      all of which taken together shall constitute a single instrument.

6.11  Arbitration. Any controversy or claim arising out of or relating to this
      Agreement, or the breach thereof, shall be settled in Denver, Colorado by
      arbitration (except as provided below), in accordance with the rules then
      obtaining, of the American Arbitration Association (the "Association"). If
      the subject of the arbitration involves an intellectual property,
      corporate, or bankruptcy matter, as determined by the Association, then
      the arbitrator(s) shall have had experience in that subject. The
      Association is authorized to make arrangements for this arbitration, to be
      held under these rules in any locality in the United States agreed upon by
      the parties or as designated by the Association. In addition, in the event
      of a dispute for which the aggrieved party seeks immediate equitable
      relief, including without limitation an injunction, the appropriate action
      may be brought in any court with appropriate jurisdiction, provided that
      any such equitable relief shall be subject to modification by the court
      after completion of arbitration of the dispute. This Agreement shall be
      enforceable, and judgment upon any award rendered by all or a majority of
      the arbitrators may be entered, in any court of any county having
      jurisdiction.

                                       3
<PAGE>

6.12  Choice of Law. This Agreement shall be construed in accordance with the
      laws of the State of Colorado of the United States without regard to
      conflicts of laws principles, and the parties agree to exclusive
      jurisdiction in the State of Colorado.

      IN WITNESS WHEREOF, the Parties have executed this Agreement, as of March
16, 2006.

CHINA AGRI-BUSINESS, INC.

By: /s/ Mark Shaner
    ---------------
    Mark Shaner, President

FRIEDLAND CORPORATE INVESTOR SERVICES LLC

By: /s/ Jeffrey O. Friedland
    ------------------------
    Jeffrey O. Friedland, Managing Member

                                       4
<PAGE>

                    Friedland Corporate Investor Services LLC
                             600 South Cherry Street
                            Suite 530 Denver CO 80246
                               Fax: 1-303-355-7176

                                                     March 19, 2007

China Agri-Business, Inc.
Finance Plaza 9th Floor
Hi-tech Road No. 42
Hi-tech Industrial Development Zone
Xi'an, Shaanxi, CHINA 710068
Tel: 011-86-29-88222938
Attn: Liping Deng

Dear Mr. Deng:

      Reference is made to the Corporate Finance Advisory Services Agreement
between China Agri-Business, Inc. ("China Agri") and Friedland Corporate
Investor Services LLC (Friedland) dated March 16, 2007.

      In consideration of the issuance of 10% of China Agri's par value $0.001
per share common stock ("Common Stock") to Friedland (or designees of Friedland)
based on the aggregate of the total outstanding shares of Common Stock before
China Agri's initial public offering and the maximum offering in the initial
public offering, the undersigned has agreed that it hereby irrevocably waives
the requirement that such share issuance should be on a fully diluted basis, as
stated under Clause 1.2 of the Agreement as well as any further anti-dilution
adjustments under Clause 1.2 in the future.

                                     Very truly yours,

                                     Friedland Corporate Investor Services LLC

                                     By: /s/ Jeffrey O. Friedland
                                         ------------------------
                                         Jeffrey O. Friedland, Managing Director

Agreed and Accepted by
China Agri-Business, Inc.

/s/ Liping Deng
---------------
By: Liping Deng, President and CEOEX-10.1

     EMPLOYMENT AGREEMENT,  dated July 10, 2007 (the "AGREEMENT"),  between
     Synovics  Pharmaceuticals,  Inc.  (the  "COMPANY"),  and Steve Getraer
     (the "EMPLOYEE").
     ----------------------------------------------------------------------

     The Company wishes to employ  Employee,  and Employee wishes to be employed
by the Company, pursuant to the terms set forth in this Agreement.

     The parties  desire to set forth the terms upon which the Employee  will be
employed by the Company.

     The parties hereby agree as follows:

     1. WORKING RELATIONSHIP.

     1.01. EMPLOYMENT.  Commencing on the date of this Agreement (the "EFFECTIVE
DATE"), the Company shall employ the Employee,  and the Employee shall serve the
Company,  as Executive Vice President and Chief Financial  Officer  ("CFO").  In
such capacity (a) Employee  shall report to, and follow the  directions  of, the
Board of Directors  (the  "BOARD") and the Chief  Executive  Officer of Synovics
Pharmaceuticals,  Inc., a Nevada  corporation (the  "COMPANY"),  (b) perform and
carry out such duties and responsibilities  that are reasonably  consistent with
Employee's position and responsibilities and this Agreement, and (c) perform and
discharge such additional duties and  responsibilities as may be determined from
time to time by the Chief Executive Officer ("CEO").

     1.02.  FULL TIME.  Commencing on the date of this  Agreement,  the Employee
shall devote his full and exclusive  business  time, as provided in Section 6.01
of this Agreement,  and energies to the performance of his duties to the Company
pursuant to this Agreement,  which duties shall be performed diligently and in a
professional  manner.  Nothing in this Agreement shall prevent the Employee from
devoting  reasonable  time and  attention  to  personal,  public and  charitable
affairs,  as  long  as such  activities  do not  interfere  with  the  effective
performance of his duties hereunder.

     1.03.  TERM. The Employee's  employment  hereunder shall commence as of the
Effective  Date and except as  otherwise  provided  in  Section 5 hereof,  shall
continue for three (3) years  following  the date hereof (the  "INITIAL  TERM").
Thereafter,  this Agreement  shall  continue,  together with any such subsequent
employment  term(s),  (being also referred to herein as the "TERM"),  unless the
Employee or Company shall have provided a written notice of termination electing
not to renew the Term to the other  party at least sixty (60) days prior to such
scheduled expiration. Upon the expiration or non-renewal of the Term pursuant to
this Section 1.03 or its  termination  pursuant to Section 5 hereof,  inclusive,
the Employee shall be released from all duties hereunder (except as set forth in
Sections 5 and 6 hereof) and the  obligations of Company to Employee shall be as
set forth in Section 5 hereof only.

<PAGE>

     2. SALARY AND BONUSES.

     2.01. SALARY. The Company shall pay a base salary to the Employee at a rate
of  US$265,000  per  calendar  year  (pro-rated  for periods of less than a full
calendar  year)  (the  "BASE  SALARY"),  payable to the  Employee  in  bi-weekly
installments in accordance with the Company's  standard salary payment policies.
The Company agrees that Employee's Base Salary shall increase  fifteen  thousand
dollars  ($15,000.00)  commencing on the thirteenth  (13th) month  following the
Effective  Date and  shall  increase  an  additional  fifteen  thousand  dollars
($15,000.00) commencing on the twenty-fifth (25th) month following the Effective
Date. Any subsequent  salary  increases  mutually agreed upon by the Company and
the Employee  (each in their  discretion)  shall be documented  in writing,  and
shall be deemed to amend this Section 2.01.

     2.02.  BONUSES.  (a) Following the end of each fiscal year during the Term,
wholly  subject to the  discretion  of the Board (or any  committee of the Board
delegated  authority  over  employee   compensation   matters)  based  upon  the
Employee's  performance  during such fiscal  year and/or  other  criteria as the
Board  may  deem  appropriate,   including  the  Company's  earnings,  financial
condition,   rate  of  return  on  equity   and   compliance   with   regulatory
requirements.,  the Company may award the Employee a bonus (the "BONUS") payable
in cash or in shares of common  stock,  par  value  $0.001 of the  Company  (the
"COMMON  STOCK"),  at the option of the Company,  for the  relevant  fiscal year
(pro-rated  for periods of less than a full fiscal year).  If any portion of the
Bonus is paid in shares of Common Stock, the Company shall pay Employee from the
Bonus an amount in cash  sufficient  to cover any  personal  Federal,  State and
local tax liability  arising out of the payment of any portion of the Bonus paid
in shares of Common Stock,  assuming the highest  marginal tax rate payable by a
resident of the State of residence of the Employee ("TAX LIABILITY PAYMENT"), it
being  understood that in no event will the Employee  receive a combined payment
of cash,  shares of Common Stock and Tax Liability  Payment that is greater than
the amount the Employee  would have  otherwise  received if payment of the Bonus
was made solely in cash.  The Company does agree that  Employee  shall receive a
guaranteed  minimum  bonus of ten percent  (10%) of Base Salary during the first
two (2) years of the Agreement. Notwithstanding anything to the contrary in this
Section  2.02 or Section 3, no annual  bonus shall be deemed to have  accrued or
otherwise to have become payable for the purposes of this Agreement  unless this
Agreement shall not have been terminated  prior to the end of the fiscal year in
respect of which such bonus was to be awarded.

          (b) PAYMENT  DATES.  Each bonus  payable  pursuant to Section  2.02(a)
shall paid on an annual  basis,  within  seventy-five  (75) days of the close of
each fiscal year,  provided,  however,  in the event that the audited  financial
statements of the Company with respect to a fiscal year are not completed within
such seventy-five (75) day period, the Board shall make a good faith estimate of
the amount  owing  pursuant  to Section  2.02(b),  if any,  payable  within such
seventy-five day period (the "GOOD FAITH PAYMENT"). The Good Faith Payment shall
be subject to (i) the Company's right to recover any  overpayment,  and (ii) the
Employee's  right to receive an  additional  payment,  each upon  completion  of
audited financials with respect to such fiscal year. Accordingly, in the case of
overpayment to the Employee,  the Employee shall be obligated to pay the Company
an amount  equal to the Good Faith  Payment,  less the amount  owed  pursuant to
Section 2.02(a), within ten (10) business days of receipt of written notice from
the

                                       2
<PAGE>

Company of such overpayment;  and, similarly,  in the case of an underpayment to
the  Employee,  the Company shall pay the Employee an amount equal to the amount
owed pursuant to Section 2.02(a),  less the Good Faith Payment,  within ten (10)
business days of the Board's final  acceptance of audited  financial  statements
from the Company's auditors.

          (c) Wholly subject to the discretion of the Board (or any committee of
the Board delegated authority over employee compensation matters) based upon the
Employee's  performance  during such fiscal  year and/or  other  criteria as the
Board  may  deem  appropriate,   including  the  Company's  earnings,  financial
condition,   rate  of  return  on  equity   and   compliance   with   regulatory
requirements.,  the  Company,  in its sole  discretion,  may  grant to  Employee
options to purchase  shares of Common  Stock or other equity  securities  of the
Company  pursuant  to any  equity  compensation  plan of the  Company  which the
Employee is eligible to participate.

     2.03 STOCK OPTIONS.  Effective upon the execution and delivery hereof,  the
Company has granted to Employee  options (the "OPTIONS") to acquire an aggregate
of 600,000  shares of Common Stock,  exercisable  for seven years at the initial
exercise price of $2.00 per share, subject to adjustment for stock splits, stock
dividends,  reverse stock splits, and recapitalizations.  The Options shall vest
in three equal annual  installments  commencing on the first  anniversary of the
date of this Agreement. The shares of Common Stock issuable upon exercise of the
Options and against payment as provided therein shall be validly  authorized and
issued, fully paid, and non-assessable. Notwithstanding other provisions of this
Section  2.03, if employee is  Terminated  Without Cause per Section  5.04(b) or
there is a Change of  Control  per  Section  5.03  prior to the end of the third
anniversary  of the  Agreement,  any and all  remaining  Options not  previously
vested shall be deemed to have been vested as of that date.

     3. EXPENSES; BENEFITS.

     3.01.  EXPENSES.  The Employee  shall be entitled to  reimbursement  by the
Company for all reasonable travel,  lodging and other expenses actually incurred
by the  Employee in  connection  with the  performance  of his  duties,  against
receipts or other appropriate  written evidence of such expenditures as required
by the appropriate  Internal  Revenue Service  regulations or by the Company and
such expenses shall be approved by the Company's  Chief  Executive  Officer as a
condition to reimbursement thereof. The Employee acknowledges that the Company's
policies  regarding the  documentation  of expenses for which  reimbursement  is
sought may change from time to time, and the Employee agrees that he will comply
with the Company's reasonable documentation requirements.

     3.02. BENEFITS. The Employee shall be entitled to participate in all health
insurance and other benefit plans  maintained by the Company for its  employees,
subject to applicable  eligibility  requirements  and, in the case of benefit or
incentive  plans  pursuant  to which the grant or award of any benefit is at the
discretion of the Board or other person,  to the discretion of the Board or such
other  person.  Nothing in the  foregoing  shall limit or restrict the Company's
discretion to amend,  revise or terminate any benefit or plan without  notice to
or consent of the Employee.

                                       3
<PAGE>

     4. VACATION AND PERSONAL DAYS. The Employee shall,  upon reasonable  notice
to the Company,  be entitled to up to twenty (20) business days of paid vacation
and personal days during each calendar  year, pro rated for periods of less than
a full calendar year;  PROVIDED,  that the timing and duration of any particular
vacation or personal day shall not interfere with the business of the Company or
the effective  performance of the  Employee's  duties  hereunder,  as reasonably
determined in good faith by the Company's Chief Executive Officer or the Board.

     5. TERMINATION OF AGREEMENT. The Employee's employment shall terminate upon
the occurrence of any one or more of the following events:

     5.01 DEATH. In the event of Employee's death,  Employee's  employment shall
terminate on the date of his death.

     5.02 TERMINATION BY THE COMPANY. The Company may, at its option,  terminate
Employee's  Employment  for any  reason,  including  for  "Cause"  or no  reason
whatsoever  by  giving a written  notice  to the  Employee  that  indicates  the
specific reasons for termination  relied upon by the Company.  Such notice shall
specify  the date of  termination,  which date shall not be earlier  than thirty
(30) days after such notice is given.  For purposes of this  Agreement,  "CAUSE"
shall  mean  (i) the  Employee's  indictment  of a felony  or a crime  involving
dishonesty,  act of moral  turpitude,  fraud  (including  securities  fraud)  or
embezzlement, (i) commission of an act of willful misconduct or gross negligence
by the Employee resulting in a material loss to the Company, (ii) the Employee's
willful  or  grossly  negligent   commission  of  an  act  which  constitutes  a
Competitive Activity, or (iii) a material breach by the Employee of any covenant
or obligation under this Agreement or written policy of the Company (unless such
policy  conflicts  with this  Agreement),  unless cured within  thirty (30) days
following  the  delivery of written  notice  thereof to the  Employee;  (iv) the
Employee's  habitual or willful  neglect or disregard of directives of the Board
of  Directors,  unless cured within  thirty (30) days  following the delivery of
written  notice thereof to the Employee;  (v)  unauthorized  appropriation  of a
material business opportunity of the Company by the Employee, including securing
any personal profit in connection with any transaction entered into on behalf of
the Company;  (vi)  misappropriation  by the Employee of the Company's  funds or
property that has a material adverse affect on the business or operations of the
Company;  (vii) any finding by the Securities and Exchange Commission pertaining
to the Employee which could reasonably be expected to impair or impede Company's
ability to maintain itself as a publicly-traded  company; or (viii) any material
misstatement is provided by the Employee for inclusion in any regulatory  report
or  public  filing of the  Company.  For  purposes  hereof,  whether  or not the
Employee  has  committed  an act of the type  referred to in clauses (i) through
(ix)  above  will be  determined  by the  Board in its  reasonable,  good  faith
discretion; PROVIDED, HOWEVER, that Employee will be given reasonable notice and
the  opportunity  to be  heard  prior  to  any  such  Board  determination.  Any
termination  by the Company of the Employee's  employment  with the Company that
does not meet the criteria set forth in this definition (determined as set forth
in the immediately  preceding  sentence) shall be deemed to be without Cause for
purposes of this Agreement.

                                       4
<PAGE>

     5.03 EMPLOYEE TERMINATION.  The Employee may, at his option,  terminate his
employment for any reason,  including for "Good Reason" or no reason  whatsoever
by giving a written  notice to the Company that  indicates the specific  reasons
for termination relied upon by the Employee.  Such notice shall specify the date
of termination, which date shall not be earlier than thirty (30) days after such
notice is given.  For purposes of this  Agreement,  "GOOD REASON" shall mean (i)
any material  breach by the Company of this  Agreement  that is not cured by the
Company  within thirty (30) days after written  notice  specifying in reasonable
detail the nature of such  material  breach is  provided  to the  Company by the
Employee or (ii) a Change of Control.  For purposes  hereof,  whether or not the
Employee has Good Reason to terminate his employment by the Company  pursuant to
clause (i) above will be determined by the Board in its  reasonable,  good faith
discretion,  based upon the facts known to the Board at the relevant  time.  Any
termination  by the  Employee of his  employment  with the Company that does not
meet the criteria set forth in this  definition  (determined as set forth in the
immediately  preceding  sentence)  shall be deemed to be without Good Reason for
purposes of this Agreement. For purposes of this Agreement,  "CHANGE OF CONTROL"
shall mean (i) the acquisition of Company pursuant to a consolidation of Company
with,  or merger of Company  with or into,  any other  person or entity with the
result of which the holders of the Company's voting stock  immediately  prior to
such transaction hold less than fifty (50%) percent of the combined voting power
after giving effect to such  transaction;  (ii) the sale of all or substantially
all of the  assets or capital  stock of  Company to any other  person or entity;
(iii) securities of Company representing greater than fifty (50%) percent of the
combined  voting power of  Company's  then  outstanding  voting  securities  are
acquired by a person or entity,  or group of related  persons or entities,  in a
single transaction or series of related  transactions,  or (iv) the voting in of
an independent  slate of Directors for the Board of Directors,  not put forth by
the  existing  Board,  which  results  in a change  in the  majority  and  gives
effective control of Directors on the Board by the new independent slate.

     5.04 OBLIGATIONS OF COMPANY  FOLLOWING  TERMINATION OF THE TERM.  Following
termination  of  Employee's   employment  under  the  respective   circumstances
described  below,  Company shall pay to Employee or his estate,  as the case may
be, the  following  compensation  and  provide  the  following  benefits in full
satisfaction  and  final  settlement  of any and all  claims  and  demands  that
Employee now has or hereafter may have hereunder  against Company.  The Employee
acknowledges  that any  non-renewal or expiration of this Agreement shall not be
deemed an event of  termination  that would trigger any  obligations  of Company
pursuant to this Section 5.

          (a)  TERMINATION  FOR CAUSE BY THE COMPANY OR  TERMINATION BY EMPLOYEE
FOR ANY REASON OTHER THAN GOOD REASON.  In the event that Employee's  employment
is  terminated  by Company for Cause  pursuant to Section  5.02 or the  Employee
terminates  his employment  with the Company for any reason  pursuant to Section
5.03, (i) the Company shall pay to the Employee,  payable in accordance with the
Company's  regular payroll  practices,  an amount equal to any unpaid but earned
Base Salary through the date of  termination,  (ii) the Company shall  reimburse
Employee for any unpaid expenses pursuant to Section 3.01 hereof; PROVIDED, THAT
the Employee has provided the Company within forty-five (45) days of the date of
termination  receipts or other appropriate written evidence of such expenditures
as required by the

                                       5
<PAGE>

appropriate  Internal  Revenue  Service  regulations  or by the Company and such
expenses had been approved by the Company's Chief Executive  Officer,  and (iii)
any unpaid Bonus approved by the Board (or any committee of the Board  delegated
authority over employee compensation matters).

          (b) TERMINATION  WITHOUT CAUSE BY THE COMPANY OR DEATH OF THE EMPLOYEE
OR  TERMINATION  BY THE EMPLOYEE FOR GOOD REASON.  In the event that  Employee's
employment  is  terminated  by Company  pursuant to Section  5.02 hereof for any
reason  other than for  "Cause" or by reason of  Employee's  death  pursuant  to
Section  5.01 hereof or by the Employee  for "Good  Reason"  pursuant to Section
5.03,  (i) the  Company  shall pay to the  Employee,  subject to the  Employee's
continued  compliance  with the terms of  Sections 6 hereof,  and  delivery of a
Release (as provided below), the Severance Amount, (ii) the Company shall pay to
the  Employee,   payable  in  accordance  with  the  Company's  regular  payroll
practices, an amount equal to any unpaid but earned Base Salary through the date
of  termination  and (iii) the Company shall  reimburse  Employee for any unpaid
expenses  pursuant to Section  3.01  hereof;  PROVIDED,  THAT the  Employee  has
provided  the Company  within  forty-five  (45) days of the date of  termination
receipts or other appropriate  written evidence of such expenditures as required
by the appropriate  Internal  Revenue Service  regulations or by the Company and
such expenses had been approved by the Company's  Chief Executive  Officer.  For
purposes hereof,  "SEVERANCE  AMOUNT" shall mean the Base Salary in effect for a
period of twelve  months.  Any  payments  made in  accordance  with this Section
5.04(b) shall be made in accordance with Company's regular payroll practices and
shall be subject to Employee's compliance with Section 6 of this Agreement.  The
breach by Employee of any provision of Section 6 shall result in a forfeiture of
any unpaid portion of the Severance  Amount.  It shall be a condition to payment
of the  Severance  Amount that the  Employee (or his estate)  shall  execute and
deliver a release,  in form and upon terms  satisfactory to the Company,  of any
claims and causes of action  against the Company (the  "RELEASE"),  and that all
time  periods  imposed by law  permitting  cancellation  or  revocation  of such
release by the Employee shall have passed or expired.

     5.05 OTHER  REMEDIES.  Nothing in this  Section 5 shall  limit or  restrict
Company from pursuing or obtaining  any other  remedies that may be available to
it in law, contract or otherwise,  in addition to the remedies set forth herein,
in response to any improper conduct of the Employee,  or conduct in violation of
the parties' agreements.

     5.06  TERMINATION  OF  COMPENSATION.   Except  as  otherwise   required  by
non-waivable  provisions of applicable law, the Employee's right to compensation
payable  pursuant to Sections 2, 3 and 5 shall,  except with  respect to amounts
which  have  accrued  and are  payable  pursuant  to  Sections 2 and 3 as of the
termination of this Agreement, terminate upon termination of this Agreement, and
no further  amounts shall accrue or be payable under this Agreement  pursuant to
such Sections.

     5.07  TERMINATION OF EMPLOYMENT;  RESIGNATION OF AUTHORITY.  The Employee's
employment by the Company shall terminate simultaneously with the termination of
this Agreement for any reason. Effective as of the termination of employment for
any reason, the Employee shall resign, in writing, from all other positions then
held by the Employee with the Company and its affiliates, if any.

                                       6
<PAGE>

     5.08  RETURN  OF  PROPERTY.  Promptly  following  the  termination  of this
Agreement  by any party for any reason,  the  Employee and his legal or personal
representatives  shall promptly  return to the Company at its principal  offices
any and all information, documents and other materials relating to or containing
Proprietary  Information  (as  defined in Section 6) which are,  and any and all
other  property of the Company which is, in the Employee's  possession,  care or
control,  regardless of whether such  materials  were created or prepared by the
Employee and  regardless of the form of, or medium  containing,  such  property,
information, documents or other materials.

     6. COVENANTS OF EMPLOYEE.

     6.01  DEVOTION  TO  DUTIES.  The  Employee  shall  devote his full time and
energies to the business, operations and activities of the Company and shall not
engage in outside business interests or activities if such activities materially
interfere with the performance of his duties.

     6.02 NON-DISCLOSURE AND ASSIGNMENT OF PROPRIETARY INFORMATION. The Employee
acknowledges that all Proprietary  Information is the exclusive  property of the
Company  or the party  that  disclosed  or  delivered  such  information  to the
Company.  The Employee  shall not use or disclose any  Proprietary  Information,
directly or  indirectly,  except as authorized by the Company in writing,  or as
needed in connection with the Employee's assigned duties, and the Employee shall
promptly  notify  the  Company  of  any  unauthorized   release  of  Proprietary
Information. The Employee agrees that all Proprietary Information developed as a
direct or indirect  result of his  efforts on behalf of the  Company  during any
period of the Employee's  employment  with the Company shall be and shall remain
the  exclusive  property of the  Company,  and that the  Employee  shall have no
ownership interests therein. To the extent the Employee may have any interest in
such  developed  Proprietary  Information,  the Employee  agrees to assign,  and
hereby does assign and  transfer,  any such  rights,  title and  interest to the
Company.  The Employee agrees to cooperate fully with the Company in taking such
actions as may be  necessary to allow the Company to secure  patent,  copyright,
trademark, trade name or other protections for any such Proprietary Information.

     6.03 NON-COMPETITION.

     (a) During  the Term,  the  Employee  shall not,  directly  or  indirectly,
participate, engage or assist in any Competitive Activities.

     (b) From the end of the Term until the first  anniversary of the end of the
Term, the Employee shall not,  directly or  indirectly,  participate,  engage or
assist in any Competitive  Activities in the United States of America;  provided
that if the  Company  does not renew the Term  beyond  the  Initial  Term or any
subsequent Term, then this Section 6.03(b) shall not apply.

     6.04  NON-SOLICITATION.  Prior to the first  anniversary  of the end of the
Term, the Employee shall not directly or indirectly solicit, recruit or hire any
(a) Person employed or retained as consultants or other independent  contractors
by the  Company or its  subsidiaries  or  affiliates,  (b)  customers,  clients,
strategic  partners,  vendors  or  suppliers  of  the  Company  or  any  of  its
subsidiaries  or  affiliates,  or (c) any  other  Person  with whom or which the
Company  or  any  of its  subsidiaries  or  affiliates  maintains  a  commercial
relationship,  or  encourage  any  such  Person  or  entity  described  above to
terminate or adversely alter their relationship with the Company

                                       7
<PAGE>

     6.05 NON-DETRIMENTAL  CONDUCT. Prior to the first anniversary of the end of
the Term, the Employee shall not, directly or indirectly,  engage in any action,
activity or course of conduct  (including the making of any unprivileged oral or
written  statement) which is, or is reasonably likely to be,  detrimental in any
material  respect to the business,  operations,  activities or reputation of the
Company.

     6.06 DEFINITIONS.  For purposes of this Section 6 the following terms shall
have the following definitions:

          (a)  "COMPETITIVE   ACTIVITIES"  means  the  following  activities  or
businesses: (i) developing,  producing, marketing, selling or distributing drugs
of any type or dietary  supplements  or services that compete with the business,
operations  or  activities  of  the  Company  or  any  of  its  subsidiaries  or
affiliates;  (ii) actively  soliciting or endeavoring to cause any Person who or
which is or was a customer,  supplier, service provider or vendor of the Company
or any of its  subsidiaries  or  affiliates  at any  time  during  the  Term  to
terminate or adversely alter the volume or nature of their business relationship
with the Company or any of its  subsidiaries  or affiliates  (including  without
limitation,  to use any products or services  that  compete  with the  business,
operations or activities of the Company or any of its subsidiaries or affiliates
if  offered  by anyone  other than the  Company  or any of its  subsidiaries  or
affiliates);  and (iii)  causing or assisting any Person or entity in any way to
do, or attempt to do, anything prohibited by clauses (i) or (ii) above, directly
or indirectly.

          (b) "PERSON" means an  individual,  a  partnership,  a corporation,  a
limited liability  company,  an association,  a joint stock company,  a trust, a
joint venture, an unincorporated  organization or any other entity,  including a
governmental entity or any department, agency or political subdivision thereof.

          (c) "PROPRIETARY  INFORMATION" means any information of a confidential
or proprietary  nature  pertaining to the Company or any of its  subsidiaries or
affiliates,  or to the business,  operations or activities of the Company or any
of its subsidiaries or affiliates,  whether or not reduced to writing,  that the
Employee,  during the Term,  knows of, has access to or  develops in whole or in
part  and  includes,   without  limitation,  the  following:  (i)  any  patents,
copyrights,  trademarks,  trade names,  trade secrets,  know-how,  inventions or
discoveries  (whether  patentable or not), or any application or license for any
of the  foregoing,  whether  acquired  on or  prior  to the  Effective  Date  or
subsequently  thereafter;  (ii) any plans,  strategies  (including  economic and
market research selection and analysis strategies and data), processes, tactics,
techniques, policies and resolutions; (iii) any information regarding litigation
or negotiations;  (iv) any financial information,  cost and performance data and
any debt arrangements,  equity ownership or securities transaction  information;
(v)  any  technical  information,   technical  drawings  and  designs,  computer
software,  source and object code;  (vi) any  personnel  information,  personnel
lists,  resumes,  personnel data,  organizational  structure,  compensation  and
performance  evaluations;  (vii) any customer,  vendor or supplier  information;
(viii) any  information  regarding  the  existence or terms of any  agreement or
relationship  between the Company or any of its  subsidiaries  or affiliates and
any other party; (ix) any other information or material relating to the business
or activities of the Company which is not generally  known to others  engaged in
similar  businesses or  activities;  and (x) any of the  information or material

                                       8
<PAGE>

described  herein  that is the  property  of any other  Person or firm which has
revealed or delivered such  information or material to the Company or any of its
subsidiaries or affiliates pursuant to a relationship (contractual or otherwise)
with  the  Company  or any  of  its  subsidiaries  or  affiliates.  "Proprietary
Information" shall not include any information or material of the type described
herein to the  extent  that  such  information  or  material  (A) is or  becomes
publicly known through no act on your part in violation of this  Agreement,  (B)
is required to be used or disclosed by applicable law or  governmental  order or
process, or (C) is known to or developed by the Employee prior to his employment
by the  Company.  The  failure  to mark any of the  Proprietary  Information  as
confidential shall not affect its status as Proprietary Information.

     6.07  IRREPARABLE  HARM. The Employee  acknowledges the valuable and unique
nature of the  Proprietary  Information  and  Company's  relationships  with its
customers,  prospective customers and employees, and admits that a breach of any
of the covenants  contained in this Section 6 may cause the Company  irreparable
harm,  for which money  damages may be  inadequate or difficult or impossible to
ascertain.  The Employee  therefore  waives (and is estopped from asserting in a
court of law or equity) any argument that the breach,  or threatened  breach, of
any of the covenants contained in this Section 6 does not constitute irreparable
harm for which an adequate  remedy at law is unavailable.  Nothing  contained in
this Section 6 or elsewhere in this Agreement  shall be construed as prohibiting
the Company from pursuing any other remedies available at law or in equity for a
breach, or threatened breach, by the Employee of any of the covenants  contained
in this Section 6.

     7. SECTION 409A.  Notwithstanding  any  provision of this  Agreement to the
contrary,  if the Employee is a "specified  employee" as defined in Section 409A
of the Internal  Revenue Code of 1986, as amended and the regulations  issued or
to be issued by the Department of the Treasury thereunder  ("SECTION 409A"), the
Employee  shall not be entitled to any payments upon a termination of employment
until the earlier of (i) the date which is six months after the  termination  of
employment for any reason other than death or (ii) the date of Employee's  death
and the first such payment  shall equal the sum of all payments  that would have
been made from the date of termination to the date of such first payment were it
not for the delay in payment for Section 409A purposes.

     8. ENTIRE AGREEMENT. This Agreement contains the entire agreement among the
parties with respect to the matters set forth herein,  and  supersedes all prior
agreements or understandings among the parties with respect to such matters.

     9. DESCRIPTIVE HEADINGS.  Descriptive headings are for convenience only and
shall not control or affect the meaning or construction of any provision of this
Agreement.

     10. NOTICES.  All notices,  requests and other  communications to any party
hereunder shall be in writing,  and shall be sufficient if delivered  personally
or sent by telecopy (with confirmation of receipt) or by registered or certified
mail, postage prepaid, return receipt requested, addressed as follows:

                                       9
<PAGE>

          If to the Employee:            Steven Getraer
                                         Flat 14,
                                         13 Cannon Hill,
                                         London, England N14 7DJ
                                         Facsimile: ___________

          If to the Company:             Synovics Pharmaceuticals, Inc.
                                         2575 East Camelback Road
                                         Suite 450
                                         Phoenix, Arizona   85016
                                         Facsimile: 602-508-0112

          With a copy to:                Reitler Brown & Rosenblatt LLC
                                         800 Third Avenue
                                         21st Floor
                                         New York, New York 10022
                                         Attention: Robert S. Brown, Esq.
                                         Facsimile: (212) 371-5500

or to such other address or telecopy number as the party to whom notice is to be
given may have furnished to the other party in writing in accordance herewith.
Each such notice, request or communication shall be effective when received or,
if given by mail, when delivered at the address specified in this Section 10 or
on the fifth business day following the date on which such communication is
posted, whichever occurs first.

     11.   COUNTERPARTS.   This  Agreement  may  be  executed  in  one  or  more
counterparts, and each such counterpart hereof shall be deemed to be an original
instrument,  but  all  such  counterparts  together  shall  constitute  but  one
agreement.

     12.  BENEFITS  OF  AGREEMENT.  All of the  terms  and  provisions  of  this
Agreement  shall be binding upon and inure to the benefit of the parties  hereto
and their respective successors and permitted assigns. This Agreement is for the
sole benefit of the parties hereto and not for the benefit of any third party.

     13.  AMENDMENTS AND WAIVERS.  No  modification,  amendment or waiver of any
provision  of, or consent  required by, this  Agreement,  nor any consent to any
departure herefrom, shall be effective unless it is in writing and signed by the
parties  hereto.  Such  modification,  amendment,  waiver  or  consent  shall be
effective  only in the  specific  instance  and for the  purpose for which it is
given.

     14.  ASSIGNMENT.  This Agreement and the rights and  obligations  hereunder
shall not be assignable or transferable without the prior written consent of the
Company.  Any  instrument  purporting to make an assignment in violation of this
Section 14 shall be void and of no effect.

                                       10
<PAGE>

     15.  GOVERNING  LAW. THIS  AGREEMENT  SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE  WITH THE LAWS OF THE STATE OF NEW YORK (WITHOUT GIVING EFFECT TO ANY
CHOICE OR CONFLICT OF LAWS PROVISIONS).

     16. CONSENT TO JURISDICTION.  EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY
AND  UNCONDITIONALLY  SUBMITS TO THE  JURISDICTION OF ANY FEDERAL COURT OR STATE
COURT OF NEW YORK  LOCATED  IN NEW YORK  CITY AND  IRREVOCABLY  AGREES  THAT ALL
ACTIONS OR  PROCEEDINGS  ARISING  OUT OF OR RELATING  TO THIS  AGREEMENT  OR THE
TRANSACTIONS  CONTEMPLATED HEREBY SHALL BE LITIGATED EXCLUSIVELY IN SUCH COURTS.
EACH OF THE PARTIES HERETO AGREES NOT TO COMMENCE ANY LEGAL  PROCEEDING  RELATED
HERETO EXCEPT IN SUCH COURT. EACH OF THE PARTIES HERETO  IRREVOCABLY  WAIVES ANY
OBJECTION WHICH HE OR IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF
ANY SUCH  PROCEEDING  IN ANY SUCH  COURT  AND  HEREBY  FURTHER  IRREVOCABLY  AND
UNCONDITIONALLY  WAIVES  AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT
ANY SUCH ACTION,  SUIT OR PROCEEDING  BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT
IN AN INCONVENIENT FORUM.

     17. WAIVER OF JURY TRIAL.  EACH OF THE PARTIES HERETO HEREBY WAIVES, TO THE
FULLEST  EXTENT  PERMITTED BY  APPLICABLE  LAW, ANY RIGHT HE OR IT MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY  LITIGATION  DIRECTLY OR INDIRECTLY  ARISING OUT
OF,  UNDER OR IN  CONNECTION  WITH THIS  AGREEMENT.  EACH OF THE PARTIES  HERETO
HEREBY (A)  CERTIFIES  THAT NO  REPRESENTATIVE,  AGENT OR  ATTORNEY OF THE OTHER
PARTY HAS REPRESENTED,  EXPRESSLY OR OTHERWISE,  THAT THE OTHER PARTY WOULD NOT,
IN THE  EVENT OF  LITIGATION,  SEEK TO  ENFORCE  THE  FOREGOING  WAIVER  AND (B)
ACKNOWLEDGES THAT HE OR IT AND THE OTHER PARTY HERETO HAVE BEEN INDUCED TO ENTER
INTO  THIS   AGREEMENT,   BY,  AMONG  OTHER  THINGS,   THE  MUTUAL  WAIVERS  AND
CERTIFICATIONS IN THIS SECTION 17.

     18.  WITHHOLDING.  The payment of any amount  pursuant  to this  Agreement,
including, without limitation, pursuant to Sections 2, 3 and 5, shall be subject
to any applicable  withholding  and payroll taxes,  which may be deducted by the
Company in its sole discretion.

     19. ADVICE OF COUNSEL. The Employee represents and warrants that he has had
full opportunity to seek advice and representation by independent counsel of his
own choosing in connection with the interpretation, negotiation and execution of
this Agreement.

     20. ENFORCEABILITY.  It is the desire and intent of the parties hereto that
the  provisions  of this  Agreement  shall be  enforced  to the  fullest  extent
permissible  under the laws and public policies applied in each  jurisdiction in
which enforcement is sought.  Accordingly,  if

                                       11
<PAGE>

any particular provision of this Agreement shall be adjudicated to be invalid or
unenforceable,  then such provision shall be deemed amended to delete  therefrom
the portion thus  adjudicated to be invalid or  unenforceable,  such deletion to
apply only with  respect to the  operation of such  provision in the  particular
jurisdiction in which such adjudication is made.

     21.  EMPLOYMENT   REPRESENTATIONS  AND  WARRANTIES.   The  Employee  hereby
represents,  warrants  and  acknowledges  to, and agrees  with,  the  Company as
follows:  (a) the Employee is not presently  subject to any  employment or other
agreement  with any other  person  or  entity  (whether  or not  engaged  in the
securities or  investment  advisory  business)  which will limit or restrict his
ability  to carry out the terms of this  Agreement  and to devote  his  business
energies  on a  full-time  basis to the Company  under this  Agreement;  (b) the
Company  has not  solicited  the  Employee  to leave his prior  employment,  and
Employee first contacted the Company to offer it his services;  (c) the Employee
is not now and has not been subject to any orders, findings, or judgments of any
securities  industry or other regulatory body and knows of no prior,  threatened
or pending  investigatory  or disciplinary  action against him by any such body;
(d) the Employee is not subject to any claims or arbitration proceedings against
him arising  from any prior  securities  activities;  (e) the  Employee  has had
sufficient  experience and knowledge in the intended activities to undertake and
perform his obligations under this Agreement;  (f) the execution and delivery by
the Employee of this Agreement,  and the Employee's performance of his duties to
the Company pursuant hereto, will not breach the terms of, or require the giving
of notice  under,  any other  agreement  to which the  Employee is a party or is
bound; (g) the Employee shall not violate any non-competition,  non-solicitation
or  non-disclosure  covenant by which the Employee is bound,  or use or disclose
any  confidential  or proprietary  information  obtained in connection  with the
Employee's   employment  by  any  previous  employer,  in  connection  with  his
employment by the Company; (h) the Employee has disclosed to the Company in full
detail all  non-competition,  non-solicitation  and non-disclosure  covenants by
which the Employee is bound as of the commencement of this Agreement.

     22.  SURVIVAL OF  PROVISIONS.  Notwithstanding  anything to the contrary in
this  Agreement,  the  provisions of Sections 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,
15, 16, 17, 19, 20, 21 and this Section 22 shall survive the termination of this
Agreement  (regardless of the manner or basis of termination) in accordance with
their terms.

              [THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]

                                       12
<PAGE>

          IN WITNESS WHEREOF,  the parties hereto have executed,  or have caused
their duly authorized representative to execute, this Employment Agreement as of
the date first written above.

                                               SYNOVICS  PHARMACEUTICALS, INC.

                                               By: /s/ RONALD H. LANE
                                                   -----------------------------
                                                   Ronald Howard Lane, Ph.D.
                                                   Chief Executive Officer

                                               EMPLOYEE:

                                               /s/ STEVE GETRAER
                                                   -----------------------------
                                                   Steve Getraer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}]]